Literature DB >> 3032715

Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.

M K Sinha, W J Pories, E G Flickinger, D Meelheim, J F Caro.   

Abstract

We have determined glucose transport, insulin binding, and insulin-receptor kinase activity in adipose tissue from morbidly obese patients with and without non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity and responsiveness of glucose transport in freshly isolated adipocytes were significantly reduced in NIDDM subjects compared with nondiabetics. This was due in part to decreased insulin binding in adipocytes. Reduced specific 125I-labeled insulin binding was also observed in crude detergent extracts and partially purified insulin receptors from adipose tissue. In addition, the basal and insulin-stimulated tyrosine-specific protein kinase activity per milligram of protein was significantly decreased in NIDDM patients compared with nondiabetics. The differences between maximally insulin-stimulated and basal kinase activities expressed by insulin-binding activity were also significantly reduced in NIDDM subjects. We conclude that insulin resistance in morbidly obese patients with NIDDM is due to both insulin-binding and postbinding defects. One of the postbinding defects in NIDDM appears to be impaired insulin-receptor kinase activity of fat tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032715     DOI: 10.2337/diab.36.5.620

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

Review 1.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

2.  Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.

Authors:  C F Kwok; B J Goldstein; D Muller-Wieland; T S Lee; C R Kahn; G L King
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 3.  Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.

Authors:  J C Byon; A B Kusari; J Kusari
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 4.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass.

Authors:  W J Pories; J F Caro; E G Flickinger; H D Meelheim; M S Swanson
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 6.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

7.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.

Authors:  G R Freidenberg; D Reichart; J M Olefsky; R R Henry
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.

Authors:  M K Sinha; L G Taylor; W J Pories; E G Flickinger; D Meelheim; S Atkinson; N S Sehgal; J F Caro
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

9.  Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.

Authors:  R V Considine; M R Nyce; L E Allen; L M Morales; S Triester; J Serrano; J Colberg; S Lanza-Jacoby; J F Caro
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.

Authors:  F Ahmad; R V Considine; B J Goldstein
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.